Showing results (41-50 of 1,290) with videos related to

Sort By:
Pageof 129
Veterinary and Comparative Oncology|July 20, 2022
Inter-pathologist agreement on diagnosis, classification and grading of canine gliomaGregory A Krane, Keith R Shockley, David E Malarkey, et al.
Veterinary and Comparative Oncology|April 16, 2022
Establishment of a new cell line of canine inflammatory mammary cancer: IMC-118Hongbo Gao, Han Zhou, Yiming Gao, et al.
Veterinary and Comparative Oncology|November 7, 2023
Effects of a high-protein, increased-fibre, dry diet supplemented with omega-3 fatty acids on quality of life in dogs undergoing chemotherapyCailin R Heinze, Kristine E Burgess, Lisa G Barber, et al.
Veterinary and Comparative Oncology|September 8, 2023
Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcomaValentina Beatriz Stevenson, Erwin Kristobal Gudenschwager-Basso, Shawna Klahn, et al.
Veterinary and Comparative Oncology|July 19, 2023
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective studyShannon A Kenny, Matthew R Cook, Jennifer A Lenz, et al.
Veterinary and Comparative Oncology|January 27, 2019
Metastatic immune infiltrates correlate with those of the primary tumour in canine osteosarcomaSita S Withers, Daniel York, Jin W Choi, et al.
Veterinary and Comparative Oncology|January 27, 2019
Clinical features and outcome of dermal squamous cell carcinoma in 193 dogs (1987-2017)Jennifer L Willcox, Stanley L Marks, Yu Ueda, et al.
Veterinary and Comparative Oncology|February 6, 2019
Canine oral primary melanoma cells exhibit shift to mesenchymal phenotype and phagocytic behaviourFranziska Schmid, Daniela Brodesser, Martin Reifinger, et al.
Veterinary and Comparative Oncology|December 22, 2019
Ultrasound is a poor predictor of early or overt liver or spleen metastasis in dogs with high-risk mast cell tumoursEvi Pecceu, Juan Carlos Serra Varela, Ian Handel, et al.
Veterinary and Comparative Oncology|November 29, 2019
The adrenergic receptor antagonists propranolol and carvedilol decrease bone sarcoma cell viability and sustained carvedilol reduces clonogenic survival and increases radiosensitivity in canine osteosarcoma cellsMegan M Duckett, Shee Kwan Phung, Linh Nguyen, et al.
Pageof 129